Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-12

FDA Approved: SILDENAFIL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves Teva's supplemental application for sildenafil, resulting in approval of a generic sildenafil product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

SUPPL AP for SILDENAFIL (SILDENAFIL)